Literature DB >> 17451896

The influence of fluid physicochemical properties on vibrating-mesh nebulization.

Thu Ghazanfari1, Abdelbary M A Elhissi, Zhiyi Ding, Kevin M G Taylor.   

Abstract

In this study, the effect of fluid physicochemical properties and the vibrating-mesh mechanism on the aerosols generated from vibrating-mesh nebulizers have been evaluated using fluids having a range of viscosity, surface tension and ion concentration. Two nebulizers were investigated: the Omron MicroAir NE-U22 (passively vibrating) and the Aeroneb Pro (actively vibrating) mesh nebulizers. For both devices, the total aerosol output was generally unaffected by fluid properties. Increased viscosity or ion concentration resulted in a decrease in droplet volume median diameter (VMD) and an increase in fine particle fraction (FPF). Moreover, increased viscosity resulted in prolonged nebulization and reduced output rate, particularly for the Omron nebulizer. Both nebulizers were unsuitable for delivery of viscous fluids since nebulization was intermittent or completely ceased at >1.92cP. The presence of ions reduced variability particularly for the Aeroneb Pro nebulizer. No clear effect of surface tension was observed on the performance of nebulizers employing a vibrating-mesh technology. However, when viscosity was low, reduced surface tension seemed advantageous in shortening the nebulization time and increasing the output rate, but for the Omron nebulizer this also increased the droplet VMD and decreased the FPF. This study has shown that vibrating-mesh nebulization was highly dependent on fluid characteristics and nebulizer mechanism of operation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451896     DOI: 10.1016/j.ijpharm.2007.02.035

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  26 in total

1.  Application of a pull on a disk method to measure surface tension of liquids.

Authors:  Thiago C Carvalho; Michelle Horng; Jason T McConville
Journal:  AAPS PharmSciTech       Date:  2012-01-19       Impact factor: 3.246

Review 2.  Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.

Authors:  Worth Longest; Benjamin Spence; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-09       Impact factor: 2.849

3.  Precision Ocular Drug Delivery Via Aerosol Ring Vortices.

Authors:  Matthew J Herpin; Hugh D C Smyth
Journal:  Pharm Res       Date:  2017-08-07       Impact factor: 4.200

4.  Inhaled Treprostinil Drug Delivery During Mechanical Ventilation and Spontaneous Breathing Using Two Different Nebulizers.

Authors:  Donna K Parker; Shuijie Shen; Jiang Zheng; D Dunbar Ivy; Dave N Crotwell; Justin C Hotz; Robert M DiBlasi
Journal:  Pediatr Crit Care Med       Date:  2017-06       Impact factor: 3.624

5.  Generation of High Concentrations of Respirable Solid-Phase Aerosols from Viscous Fluids.

Authors:  Xin Heng; Donovan B Yeates
Journal:  Aerosol Sci Technol       Date:  2018-07-30       Impact factor: 2.908

6.  MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France.

Authors:  Elsa Bodier-Montagutelli; Renaud Respaud; Hervé Watier; Audrey Guillon-Munos
Journal:  MAbs       Date:  2017-02-28       Impact factor: 5.857

Review 7.  In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.

Authors:  Lucy E A Hardaker; Ross H M Hatley
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

8.  Nebulization of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury.

Authors:  Soraya Hengsawas Surasarang; Sawittree Sahakijpijarn; Galina Florova; Andrey A Komissarov; Christina L Nelson; Enkhbaatar Perenlei; Satoshi Fukuda; Marla R Wolfson; Thomas H Shaffer; Steven Idell; Robert O Williams
Journal:  J Drug Deliv Sci Technol       Date:  2018-04-30       Impact factor: 3.981

9.  In vitro evaluation of the inhalable quercetin loaded nanoemulsion for pulmonary delivery.

Authors:  Noor Hafizah Arbain; Norazlinaliza Salim; Hamid Reza Fard Masoumi; Tin Wui Wong; Mahiran Basri; Mohd Basyaruddin Abdul Rahman
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

10.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.